These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 36261756)

  • 1. Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?
    Sato R; Vatic M; da Fonseca GWP; von Haehling S
    Curr Heart Fail Rep; 2022 Dec; 19(6):400-411. PubMed ID: 36261756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between inflammation and skeletal muscle proteolysis, skeletal mass and strength in elderly heart failure patients and their prognostic implications.
    Koshikawa M; Harada M; Noyama S; Kiyono K; Motoike Y; Nomura Y; Nishimura A; Izawa H; Watanabe E; Ozaki Y
    BMC Cardiovasc Disord; 2020 May; 20(1):228. PubMed ID: 32414332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating H-FABP as a biomarker of frailty in patients with chronic heart failure.
    Ahmad F; Karim A; Khan J; Qaisar R
    Exp Biol Med (Maywood); 2023 Aug; 248(16):1383-1392. PubMed ID: 37787063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the prevalence and prognostic impact of physical frailty and sarcopenia among older patients with heart failure.
    Maeda D; Matsue Y; Kagiyama N; Jujo K; Saito K; Kamiya K; Saito H; Ogasahara Y; Maekawa E; Konishi M; Kitai T; Iwata K; Wada H; Hiki M; Dotare T; Sunayama T; Kasai T; Nagamatsu H; Ozawa T; Izawa K; Yamamoto S; Aizawa N; Wakaume K; Oka K; Momomura SI; Minamino T
    Nutr Metab Cardiovasc Dis; 2022 Feb; 32(2):365-372. PubMed ID: 34893406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure.
    Rehman SU; Mueller T; Januzzi JL
    J Am Coll Cardiol; 2008 Oct; 52(18):1458-65. PubMed ID: 19017513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of biomarkers in patients with chronic heart failure and healthy controls.
    Meijers WC; van der Velde AR; Muller Kobold AC; Dijck-Brouwer J; Wu AH; Jaffe A; de Boer RA
    Eur J Heart Fail; 2017 Mar; 19(3):357-365. PubMed ID: 27766733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
    Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
    Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate biomarkers of physical frailty in heart failure: an exploratory cross-sectional study.
    Denfeld QE; Purnell JQ; Lee CS; Orwoll ES; Camacho SA; Hiatt SO; Roberts Davis M; Winters-Stone K; Woodward WR; Habecker BA
    Eur J Cardiovasc Nurs; 2023 Mar; 22(2):149-157. PubMed ID: 35727092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of frailty and sarcopenia in hospitalised older people.
    Echeverria I; Besga A; Sanz B; Amasene M; Hervás G; Barroso J; Rodriguez-Larrad A; Irazusta J
    Eur J Clin Invest; 2021 Apr; 51(4):e13420. PubMed ID: 33020908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise and nutritional interventions on sarcopenia and frailty in heart failure: a narrative review of systematic reviews and meta-analyses.
    Prokopidis K; Isanejad M; Akpan A; Stefil M; Tajik B; Giannos P; Venturelli M; Sankaranarayanan R
    ESC Heart Fail; 2022 Oct; 9(5):2787-2799. PubMed ID: 35840310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolism to Catabolism: Serologic Clues to Nutritional Status in Heart Failure.
    Murphy L; Gray A; Joyce E
    Curr Heart Fail Rep; 2019 Oct; 16(5):189-200. PubMed ID: 31606846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.
    Mueller T; Gegenhuber A; Leitner I; Poelz W; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2016 Dec; 463():158-164. PubMed ID: 27983996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of estimating appendicular muscle mass in heart failure using creatinine/cystatin C.
    Sunayama T; Fujimoto Y; Matsue Y; Dotare T; Daichi M; Yatsu S; Ishiwata S; Nakamura Y; Akama Y; Tsujimura Y; Suda S; Kato T; Hiki M; Kasai T; Minamino T
    Nutr Metab Cardiovasc Dis; 2023 Sep; 33(9):1733-1739. PubMed ID: 37407312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise as a Therapeutic Strategy for Sarcopenia in Heart Failure: Insights into Underlying Mechanisms.
    Cho J; Choi Y; Sajgalik P; No MH; Lee SH; Kim S; Heo JW; Cho EJ; Chang E; Kang JH; Kwak HB; Park DH
    Cells; 2020 Oct; 9(10):. PubMed ID: 33066240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myostatin as a Biomarker for Diagnosis or Prognosis of Frailty and Sarcopenia: Current Knowledge.
    Arrieta H; Rodriguez-Larrad A; Irazusta J
    Gerontology; 2019; 65(4):385-386. PubMed ID: 30820018
    [No Abstract]   [Full Text] [Related]  

  • 18. Background and Design of the Biological and Physiological Mechanisms of Symptom Clusters in Heart Failure (BIOMES-HF) Study.
    Denfeld QE; Camacho SA; Dieckmann N; Hiatt SO; Roberts Davis M; Cramer DV; Rupert A; Habecker BA; Lee CS
    J Card Fail; 2022 Jun; 28(6):973-981. PubMed ID: 35045322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the Eyeball Test: Grip Strength at the Nexus of Frailty, Cachexia and Sarcopenia in Heart Failure.
    Burke MA
    J Card Fail; 2023 Jun; 29(6):919-921. PubMed ID: 36907235
    [No Abstract]   [Full Text] [Related]  

  • 20. ST2 elevation in heart failure, predictive of a high early mortality.
    Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
    Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.